An im­por­tant crim­i­nal re­fer­ral

Pro-life Repub­li­can leg­is­la­tors take aim at Planned Par­ent­hood and its af­fil­i­ates

The Washington Times Daily - - COMMENTARY - By Kelly Rid­dell

One day in June 2014, Ad­vanced Bio­science Re­sources (ABR) ob­tained a 20-week-old fe­tus at a Planned Par­ent­hood clinic, for which it paid $60. From that one fe­tus, ABR sold its brain to a cus­tomer for $325; both of its eyes for $325 each ($650 to­tal); a por­tion of its liver for $325 to a third cus­tomer; its thy­mus for $325 and an­other por­tion of the liver for $325 to a forth cus­tomer; and its lung for $325 to a fifth cus­tomer.

In to­tal, ABR charged its clients $2,275 for a fe­tus it paid $60 for — which didn’t in­clude sep­a­rate, ad­di­tional charges for ship­ping and dis­ease screen­ing.

That day in the Planned Par­ent­hood clinic, ABR was able to ob­tain four aborted fe­tuses with tis­sue sam­ples that to­taled $6,825. ABR was able to dis­sect and ship out the baby parts all within a four hour work pe­riod, where it’s di­rect costs to­taled a mere $350. The com­pany made a $6,525 profit all in a par­tial days work.

This week, Se­nate Ju­di­ciary Chair­man Chuck Grass­ley re­ferred ABR, along with other com­pa­nies in­volved with fe­tal tis­sue trans­fers — StemEx­press, and Novo­genix Lab­o­ra­to­ries — and sev­eral Planned Par­ent­hood af­fil­i­ates and the Planned Par­ent­hood Fed­er­a­tion of Amer­ica to the FBI and the De­part­ment of Jus­tice for in­ves­ti­ga­tion and pos­si­ble pros­e­cu­tion.

The rec­om­men­da­tion was based on find­ings of a year-long in­ves­ti­ga­tion the

com­mit­tee did into the fe­tal-tis­sue mar­ket af­ter the Center for Med­i­cal Progress (CMP) be­gan re­leas­ing a se­ries of un­der­cover videos re­gard­ing baby parts traf­fick­ing.

The com­mit­tee’s rev­e­la­tions are not based on the CMP videos, but rather 20,000 pages and doc­u­ments pro­vided vol­un­tar­ily by the par­ties, in­clud­ing con­tracts, in­voices, in­ter­nal cost cal­cu­la­tions, med­i­cal stan­dards and guide­lines, tech­ni­cian com­pen­sa­tion poli­cies and tis­sue pro­cure­ment logs.

“I don’t take lightly mak­ing a crim­i­nal re­fer­ral. But, the seem­ing dis­re­gard for the law by these en­ti­ties has been fu­eled by decades of ut­ter fail­ure by the Jus­tice De­part­ment to en­force it,” Mr. Grass­ley said in a state­ment this week. “And, un­less there is a re­newed com­mit­ment by ev­ery­one in­volved against com­mer­cial­iz­ing the trade in aborted fe­tal body parts for profit, then the prob­lem is likely to con­tinue.”

In 1993, the House passed the Na­tional In­sti­tutes of Health Re­vi­tal­iza­tion Act which was in­tended to out­law the com­mer­cial mar­ket for fe­tal tis­sue. Dur­ing the 14 years since the law’s pas­sage, the De­part­ment of Health and Hu­man Ser­vices has never con­ducted a sin­gle au­dit to en­sure it was be­ing en­forced, and the Jus­tice De­part­ment hasn’t ini­ti­ated a sin­gle pros­e­cu­tion.

In ad­di­tion to vi­o­lat­ing the 1993 law, Mr. Grass­ley’s com­mit­tee be­lieves fur­ther in­ves­ti­ga­tion into the mas­sive or­gan traf­fick­ing scheme may re­veal vi­o­la­tions of the par­tial birth abor­tion ban, ob­tain­ing or­gans from still-liv­ing aborted fe­tuses, and al­ter­cat­ing abor­tion pro­ce­dures in or­der to ob­tain fe­tal tis­sue.

Some ab­hor­rent stuff, if the Obama ad­min­is­tra­tion were will­ing to in­ves­ti­gate. In­stead, Mr. Obama has been work­ing over­time to pro­tect Planned Par­ent­hood. Just this week, the HHS is­sued a rule that bars states from de­fund­ing abor­tion providers through Ti­tle X funds.

Mr. Grass­ley’s com­mit­tee found that Planned Par­ent­hood had poli­cies in place to en­sure its af­fil­i­ates weren’t break­ing the law when it came to their fe­tal tis­sue pro­grams, but when it learned its af­fil­i­ates were not fol­low­ing their guide­lines in Jan­uary 2011, in­stead of en­forc­ing them, Planned Par­ent­hood de­cided to turn a blind eye.

It was only in the weeks prior to the CMP’s videos re­lease in 2015, did Planned Par­ent­hood re­in­state its guide­lines, and add a new sec­tion to specif­i­cally ad­dress fe­tal tis­sue pay­ments. These guide­lines are ones that Planned Par­ent­hood Pres­i­dent Ce­cile Richards re­peat­edly re­ferred to when she de­fended her or­ga­ni­za­tion to Congress — fail­ing to men­tion they had only been in place for a few weeks.

Thank good­ness a new sher­iff is com­ing to town in Jan­uary.

If Sen. Jeff Ses­sions is ap­pointed at­tor­ney gen­eral of the Jus­tice De­part­ment, you can ex­pect all laws will be en­forced — not just some, se­lec­tively up­held, with oth­ers ig­nored. Pros­e­cu­tions will be made based on ev­i­dence, not po­lit­i­cal pref­er­ence.

In Congress, pro-life Repub­li­cans are lead­ing an am­bi­tious agenda to take on Planned Par­ent­hood, which in­cludes de­fund­ing the gi­ant abor­tion provider and in­ves­ti­gat­ing its prac­tices.

Ms. Richards warned in a Tues­day fundrais­ing plea that pro-choice ad­vo­cates can ex­pect “the fight of our lives” in a world with­out Pres­i­dent Obama.

For the fu­ture of Amer­ica’s ba­bies, we pray that’s the case.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.